Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
2.390
+0.070 (3.02%)
Nov 22, 2024, 4:00 PM EST - Market closed
Alaunos Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 4 | 17 | 155 | 234 | 537 | 847 | |
| Market Cap Growth | -83.70% | -89.08% | -33.56% | -56.40% | -36.65% | 220.77% | |
| Enterprise Value | 2 | 6 | 143 | 172 | 404 | 760 | |
| Last Close Price | 2.39 | 10.60 | 97.36 | 163.50 | 378.00 | 708.00 | |
| PS Ratio | 736.58 | 3396.28 | 53.20 | 587.82 | - | - | |
| PB Ratio | 1.40 | 2.69 | 4.03 | 4.03 | 4.33 | 8.92 | |
| P/TBV Ratio | 1.89 | 2.69 | 4.03 | 4.03 | 4.33 | 8.92 | |
| EV/Sales Ratio | 306.28 | 1241.68 | 49.00 | 431.80 | - | - | |
| Debt / Equity Ratio | - | - | 0.51 | 0.51 | 0.04 | 0.02 | |
| Asset Turnover | 0.00 | 0.00 | 0.04 | 0.00 | - | - | |
| Quick Ratio | 2.04 | 3.10 | 1.62 | 4.81 | 6.52 | 6.63 | |
| Current Ratio | 4.30 | 4.22 | 2.23 | 4.91 | 7.11 | 8.42 | |
| Return on Equity (ROE) | -141.72% | -156.66% | -78.11% | -86.52% | -73.04% | -130.47% | |
| Return on Assets (ROA) | -40.33% | -48.66% | -25.61% | -37.91% | -39.32% | -35.42% | |
| Return on Capital (ROIC) | -52.10% | -55.33% | -28.13% | -42.29% | -44.42% | -39.54% | |
| Earnings Yield | -307.81% | -206.93% | -24.27% | -33.66% | -14.90% | -13.91% | |
| FCF Yield | -307.40% | -178.66% | -18.94% | -27.69% | -12.45% | -4.86% | |
| Buyback Yield / Dilution | -1.88% | -10.50% | -1.27% | -2.27% | -24.82% | -16.87% | |
| Total Shareholder Return | -1.88% | -10.50% | -1.27% | -2.27% | -24.82% | -16.87% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.